Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community

Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any cont...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2008-01, Vol.14, p.124-133
Hauptverfasser: Warren, R.E., Harvey, G., Carr, R., Ward, D., Doroshenko, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133
container_issue
container_start_page 124
container_title Clinical microbiology and infection
container_volume 14
creator Warren, R.E.
Harvey, G.
Carr, R.
Ward, D.
Doroshenko, A.
description Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.
doi_str_mv 10.1111/j.1469-0691.2007.01870.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70163839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14604833</els_id><sourcerecordid>70163839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</originalsourceid><addsrcrecordid>eNqNkU2O1DAQhSPEiBkGroC8YpdQjhPHXrCAFn9So9mAxM5y7MqMW4nd2Al0X4uDcKZx6BYsGW9ccr33qvS5KAiFiubzalfRhssSuKRVDdBVQEUH1eFRcfW38TjXVIqya9i3y-JpSjsAqBlrnhSXVNC2aRm_Kvwm-DmGkYSBOD-gmV3widgFyRwIHmb0Fm2Z9rkTl4n8_lWO2sx60gnLfQx2Mc7fkhBvtXdpSjmE3IW0d7MeE9HekvkOiQnTtHg3H58VF0Nu4PPzfV18ff_uy-Zjub358GnzZluapuNQSi5xkIJaIXXDoAbTWylA99S0LYihp9QCb2nfsFozDryrIb_UEoVpO96z6-LlKTev-H3BNKvJJYPjqD2GJakOKGeCySwUJ6GJIaWIg9pHN-l4VBTUylrt1IpUrUjVylr9Ya0O2friPGPpJ7T_jGe4WfD6JPjpRjw-OFhttp_XKvvfnvyYSf1wGFUyDr1B62L-DmWD-_-W99vBpGY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70163839</pqid></control><display><type>article</type><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</creator><creatorcontrib>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</creatorcontrib><description>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2007.01870.x</identifier><identifier>PMID: 18154536</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Bacteremia - epidemiology ; Bacteremia - microbiology ; Bacteremia - prevention &amp; control ; beta-Lactamases - biosynthesis ; Carriage ; Carrier State - microbiology ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Community-Acquired Infections - prevention &amp; control ; control ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Cross Infection - prevention &amp; control ; Drug Resistance, Multiple, Bacterial ; E. coli ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli Infections - epidemiology ; Escherichia coli Infections - microbiology ; Escherichia coli Infections - prevention &amp; control ; extended-spectrum β-lactamases ; Humans ; Infection Control - methods ; review ; United Kingdom - epidemiology ; urinary infection ; Urinary Tract Infections - epidemiology ; Urinary Tract Infections - microbiology ; Urinary Tract Infections - prevention &amp; control</subject><ispartof>Clinical microbiology and infection, 2008-01, Vol.14, p.124-133</ispartof><rights>2008 European Society of Clinical Infectious Diseases</rights><rights>2008 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</citedby><cites>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2007.01870.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2007.01870.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18154536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warren, R.E.</creatorcontrib><creatorcontrib>Harvey, G.</creatorcontrib><creatorcontrib>Carr, R.</creatorcontrib><creatorcontrib>Ward, D.</creatorcontrib><creatorcontrib>Doroshenko, A.</creatorcontrib><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacteremia - epidemiology</subject><subject>Bacteremia - microbiology</subject><subject>Bacteremia - prevention &amp; control</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Carriage</subject><subject>Carrier State - microbiology</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Community-Acquired Infections - prevention &amp; control</subject><subject>control</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Cross Infection - prevention &amp; control</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>E. coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli Infections - epidemiology</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Escherichia coli Infections - prevention &amp; control</subject><subject>extended-spectrum β-lactamases</subject><subject>Humans</subject><subject>Infection Control - methods</subject><subject>review</subject><subject>United Kingdom - epidemiology</subject><subject>urinary infection</subject><subject>Urinary Tract Infections - epidemiology</subject><subject>Urinary Tract Infections - microbiology</subject><subject>Urinary Tract Infections - prevention &amp; control</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2O1DAQhSPEiBkGroC8YpdQjhPHXrCAFn9So9mAxM5y7MqMW4nd2Al0X4uDcKZx6BYsGW9ccr33qvS5KAiFiubzalfRhssSuKRVDdBVQEUH1eFRcfW38TjXVIqya9i3y-JpSjsAqBlrnhSXVNC2aRm_Kvwm-DmGkYSBOD-gmV3widgFyRwIHmb0Fm2Z9rkTl4n8_lWO2sx60gnLfQx2Mc7fkhBvtXdpSjmE3IW0d7MeE9HekvkOiQnTtHg3H58VF0Nu4PPzfV18ff_uy-Zjub358GnzZluapuNQSi5xkIJaIXXDoAbTWylA99S0LYihp9QCb2nfsFozDryrIb_UEoVpO96z6-LlKTev-H3BNKvJJYPjqD2GJakOKGeCySwUJ6GJIaWIg9pHN-l4VBTUylrt1IpUrUjVylr9Ya0O2friPGPpJ7T_jGe4WfD6JPjpRjw-OFhttp_XKvvfnvyYSf1wGFUyDr1B62L-DmWD-_-W99vBpGY</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Warren, R.E.</creator><creator>Harvey, G.</creator><creator>Carr, R.</creator><creator>Ward, D.</creator><creator>Doroshenko, A.</creator><general>Elsevier Ltd</general><general>Blackwell Publishing Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200801</creationdate><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><author>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacteremia - epidemiology</topic><topic>Bacteremia - microbiology</topic><topic>Bacteremia - prevention &amp; control</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Carriage</topic><topic>Carrier State - microbiology</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Community-Acquired Infections - prevention &amp; control</topic><topic>control</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Cross Infection - prevention &amp; control</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>E. coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli Infections - epidemiology</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Escherichia coli Infections - prevention &amp; control</topic><topic>extended-spectrum β-lactamases</topic><topic>Humans</topic><topic>Infection Control - methods</topic><topic>review</topic><topic>United Kingdom - epidemiology</topic><topic>urinary infection</topic><topic>Urinary Tract Infections - epidemiology</topic><topic>Urinary Tract Infections - microbiology</topic><topic>Urinary Tract Infections - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warren, R.E.</creatorcontrib><creatorcontrib>Harvey, G.</creatorcontrib><creatorcontrib>Carr, R.</creatorcontrib><creatorcontrib>Ward, D.</creatorcontrib><creatorcontrib>Doroshenko, A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warren, R.E.</au><au>Harvey, G.</au><au>Carr, R.</au><au>Ward, D.</au><au>Doroshenko, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2008-01</date><risdate>2008</risdate><volume>14</volume><spage>124</spage><epage>133</epage><pages>124-133</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>18154536</pmid><doi>10.1111/j.1469-0691.2007.01870.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2008-01, Vol.14, p.124-133
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_70163839
source MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Anti-Bacterial Agents - pharmacology
Bacteremia - epidemiology
Bacteremia - microbiology
Bacteremia - prevention & control
beta-Lactamases - biosynthesis
Carriage
Carrier State - microbiology
Community-Acquired Infections - epidemiology
Community-Acquired Infections - microbiology
Community-Acquired Infections - prevention & control
control
Cross Infection - epidemiology
Cross Infection - microbiology
Cross Infection - prevention & control
Drug Resistance, Multiple, Bacterial
E. coli
Escherichia coli - drug effects
Escherichia coli - enzymology
Escherichia coli Infections - epidemiology
Escherichia coli Infections - microbiology
Escherichia coli Infections - prevention & control
extended-spectrum β-lactamases
Humans
Infection Control - methods
review
United Kingdom - epidemiology
urinary infection
Urinary Tract Infections - epidemiology
Urinary Tract Infections - microbiology
Urinary Tract Infections - prevention & control
title Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A00%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20infections%20due%20to%20extended-spectrum%20%CE%B2-lactamase-producing%20organisms%20in%20hospitals%20and%20the%20community&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Warren,%20R.E.&rft.date=2008-01&rft.volume=14&rft.spage=124&rft.epage=133&rft.pages=124-133&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2007.01870.x&rft_dat=%3Cproquest_cross%3E70163839%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70163839&rft_id=info:pmid/18154536&rft_els_id=S1198743X14604833&rfr_iscdi=true